Impact of mutations conferring reduced susceptibility to lamivudine on the response to antiretroviral therapy

Antiviral Therapy

Volumn 6, Issue 3, 2001, Pages 195-198

  Perno, C F ^a   Cozzi Lepri, A ^a   Balotta, C ^a   Forbici, F ^a   Violin, M ^a   Bertoli, A ^a   Facchi, G ^a   Pezzotti, P ^a   Angarano, G ^a,a   Arici, C ^a   Narciso, P ^a   Orani, A ^a   Raise, E ^a   Scalzini, A ^a   Poggio, A ^a   Ippolito, G ^a   Moroni, M ^a,a   D'Arminio Monforte, A ^a   Montroni, M ^a   Scalise, G ^a   Costantini, A ^a   Del Prete, M S ^a   Tirelli, U ^a   Nasti, G ^a   Pastore, G ^a   Perulli, L M ^a   Suter, F ^a   Chiodo, F ^a   Gritti, F M ^a   Colangeli, V ^a   Fiorini, C ^a   Guerra, L ^a   Carosi, G ^a   Cadeo, G P ^a   Castelli, F ^a   Minardi, C ^a   Vangi, D ^a   Rizzardini, G ^a   Migliorino, G ^a   Manconi, P E ^a   Piano, P ^a   Ferraro, T ^a   Cosco, L ^a   Pizzigallo, E ^a   Ricci, F ^a   Vigevani, G M ^a   Pusterla, L ^a   Carnevale, G ^a   Pan, A ^a   Vigano P ^a   Mena, M ^a   Ghinelli, F ^a   Sighinolfi, L ^a   Leoncini, F ^a   Mazzotta, F ^a   Ambu, S ^a   Lo Caputo, S ^a   Grisorio, B ^a   Ferrara, S ^a   Grima, P ^a   Tundo, P ^a   Pagano, G ^a   Piersantelli, N ^a   Alessandrini, A ^a   Piscopo, R ^a   Toti, M ^a   Chigiotti, ^a   Soscia, F ^a   Tacconi, L ^a   Castaldo, G ^a   Scasso, A ^a   Vincenti, A ^a   Scalzini, F ^a   Alessi, F ^a   more..

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ADULT; AGED; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIRUS GENE; VIRUS MUTATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DRUG RESISTANCE, VIRAL; FEMALE; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; LAMIVUDINE; MALE; MIDDLE AGED; MUTATION; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 0035663269     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. A novel human immunodeficiency virus type 1 reverse trascriptase mutational pattern confers phenotypic lamivudine resistance in the absence of mutation 184
2. Prevalence and conditions of selection of 44D and/or 118I RT mutations in clinical practice
3. Prevalence of novel lamivudine-resistant genotypes (E44D/A, V118I) in naive and pretreated HIV-infected individuals
4. Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen and its determinants in a clinical cohort of antiretroviral naïve patients
5. Antiretroviral drug resistance testing in adult HIV-1 infection
6. Resistance table: Mutations in retroviral genes associated with drug-resistance: 1999-2000 Update